Form 4: OptimizeRx Executive Stephen Silvestro Reports Stock Transactions
SEC Form 4 Filing
Stephen Silvestro, Chief Commercial Officer of OptimizeRx Corp, reports the vesting and subsequent disposal of shares to cover tax obligations.
Summary
- On March 1, 2024, Stephen Silvestro, the Chief Commercial Officer of OptimizeRx Corp, had restricted stock units vest and converted into 1,927 shares of common stock.
- Simultaneously, 668 shares were disposed of at a price of $15.95 to cover tax withholding obligations.
- Following these transactions, Silvestro directly owns 5,956 shares of common stock and 1,928 restricted stock units.
- The restricted stock units vest in three equal annual installments beginning March 1, 2023.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 03/01/2023 | First anniversary of the grant date for restricted stock units, with vesting in three equal annual installments. |
| 03/01/2024 | Date of stock transactions: vesting of restricted stock units and disposal of shares for tax obligations. |
| 03/06/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.